Lenox Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$163K Sell
1,858
-114
-6% -$8.99K 0.02% 125
2021
Q4
$151K Buy
1,972
+50
+3% +$3.98K 0.02% 133
2021
Q3
$144K Buy
1,922
+131
+7% +$9.96K 0.02% 131
2021
Q2
$139K Buy
1,791
+15
+0.8% +$1.12K 0.02% 134
2021
Q1
$131K Sell
1,776
-494
-22% -$36.4K 0.02% 110
2020
Q4
$177K Buy
2,270
+15
+0.7% +$1.15K 0.03% 90
2020
Q3
$178K Sell
2,255
-45
-2% -$3.52K 0.03% 85
2020
Q2
$170K Buy
2,300
+120
+6% +$9.03K 0.03% 77
2020
Q1
$160K Buy
2,180
+5
+0.2% +$393 0.03% 72
2019
Q4
$189K Buy
2,175
+88
+4% +$7.23K 0.03% 85
2019
Q3
$168K Buy
2,087
+126
+6% +$10.1K 0.03% 86
2019
Q2
$157K Buy
1,961
+216
+12% +$16.5K 0.03% 85
2019
Q1
$138K Buy
1,745
+5
+0.3% +$374 0.03% 88
2018
Q4
$127K Buy
1,740
+5
+0.3% +$353 0.03% 89
2018
Q3
$117K Buy
1,735
+804
+86% +$51.2K 0.02% 96
2018
Q2
$54K Sell
931
-538
-37% -$30.4K 0.01% 129
2018
Q1
$76K Buy
1,469
+710
+94% +$38.3K 0.02% 126
2017
Q4
$41K Buy
759
+79
+12% +$4.38K 0.01% 106
2017
Q3
$42K Buy
680
+19
+3% +$1.15K 0.01% 57
2017
Q2
$40K Buy
661
+5
+0.8% +$304 0.01% 69
2017
Q1
$40K Buy
656
+5
+0.8% +$303 0.01% 52
2016
Q4
$37K Sell
651
-3,097
-83% -$181K 0.01% 61
2016
Q3
$223K Sell
3,748
-137
-4% -$8.01K 0.07% 31
2016
Q2
$214K Sell
3,885
-87
-2% -$4.63K 0.06% 34
2016
Q1
$201K Sell
3,972
-24
-0.6% -$1.18K 0.06% 37
2015
Q4
$201K Sell
3,996
-240
-6% -$12.1K 0.06% 34
2015
Q3
$200K Buy
4,236
+1,036
+32% +$55K 0.07% 32
2015
Q2
$174K Sell
3,200
-698
-18% -$39.1K 0.07% 34
2015
Q1
$214K Buy
3,898
+90
+2% +$5.1K 0.09% 32
2014
Q4
$206K Sell
3,808
-312
-8% -$17.4K 0.09% 31
2014
Q3
$233K Sell
4,120
-599
-13% -$33.6K 0.1% 25
2014
Q2
$262K Buy
4,719
+950
+25% +$51.8K 0.12% 17
2014
Q1
$203K Sell
3,769
-283
-7% -$14.7K 0.12% 19
2013
Q4
$194K Buy
4,052
+2,986
+280% +$136K 0.14% 25
2013
Q3
$48K Sell
1,066
-556
-34% -$25.4K 0.04% 36
2013
Q2
$72K Buy
+1,622
New +$72.4K 0.08% 24

Other funds holding MRK

Lenox Wealth Advisors's MRK Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its Merck (MRK) stake by 5.8% in Q1 2022, selling an estimated $8.99K and leaving 1,858 shares worth $163K. The position accounts for 0.02% of the portfolio, ranked #125.

Lenox Wealth Advisors first reported a position in MRK in Q2 2013 and has held it in 36 quarters since. The position peaked at $262K in Q2 2014. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Lenox Wealth Advisors held 1,858 shares of Merck worth $163K as of Q1 2022.
  • Lenox Wealth Advisors sold 114 Merck shares in Q1 2022, an estimated $8.99K.
  • Merck made up 0.02% of Lenox Wealth Advisors's portfolio in Q1 2022, its #125 holding.
  • Lenox Wealth Advisors first reported a position in Merck in Q2 2013 and has held it in 36 quarters since.
  • Lenox Wealth Advisors's Merck position peaked at $262K in Q2 2014.
  • 2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.